Case File
efta-02693495DOJ Data Set 11OtherEFTA02693495
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02693495
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Sent:
Wednesday, February 5, 2014 6:31 PM
To:
Jeffrey Epstein
Subject:
Fwd: ATorus - Daily Portfolio Report - 2/3 & 2/4
Attachments:
Atorus_BacktestNAV_020314.pdf; Untitled attachment 00509.htm;
Atorus_BacktestNAV_020414.pdf; Untitled attachment 00512.htm
Sent from my iPhone
Begin forwarded message:
From: Michael Fowler
Date: Februa
5, 2014, 1:26:38 PM EST
To
Subject: ATorus - Daily Portfolio Report - 2/3 & 2/4
I've attached Daily Portfolio Report for 2/3/14 and 2/4/14. Also, below is a short daily commentary.
Daily Commentary:
"Always Catching the Big Move"
Inherent to the foundation of the strategy, is the ability to get generate positive absolute returns in significant
market declines (where many years of gains can be eliminated in short order). We consistently say "we are not worried
about catching the big move in either direction." A case in point is the current short position in OGXP3 BZ Equity. In this
case, we received a short signal on April 2012 at 4.45. The price has subsequently fallen to 0.11. During this period we
added to the position, as to leverage the winners. To the extent broad markets were to experience a move similar to the
decline in OGXP3 BZ, the fund would generate returns similar to those experienced in that position.
"Impact of Correlation, Vol, & Leverage on NAV"
We have what we believe is a unique dynamic approach in managing correlation and volatility (position sizing &
global universe opportunity set), wherein we do not over manage and thereby severely reduce absolute returns. Yet
varying correlations and realized volatility are states of the system/market and are out of our control in terms of
effecting them. We can only mange them prudently.
"You want a valve that doesn't leak and you try everything to develop one, but the real world provides you with
a leaky valve. You have to determine how much leaking you can tolerate" - Arthur Rudolph, scientist who developed first
Saturn 5 rocket for Apollo mission
EFTA_R1_02037904
EFTA02693495
Specifically, in periods of significant consistent directionality (in other words a lot of correlation) our daily
volatility will increase, but with right way risk. Since we leverage winners when experiencing +MTM gains, naturally our
daily vol increases at potential inflection points. Longer term correlations do not spike to 1 or -1 in short intervals as the
required variance would have to be multiples of the total variance. The correlations we measure (in units of time) are
proportional to our targeted return profile, which as we've noted previously, occur over longer term intervals of time.
With our broad universe of securities, which reduces correlation, we mitigate the potential of all our respective positions
receiving the same trade signals at the same. Naturally, some securities will receive an opposing signal, and our net
exposures will be reduced. Yet changes in our net exposure oscillating between short or long occurs infrequently (8
times since 1995).
Best Regards,
Michael 1. Fowler
Intl. Mobile
Sent From My Mobile Device
The information contained in this electronic mail message is confidential information intended only for the use
of the individual or entity named above, and may be privileged. If the reader of this message is not the intended
recipient, you are hereby notified that any dissemination, distribution, or copying of this message is strictly prohibited. If
you have recieved this communication in error, please immediately notify us by telephone, and delete the original
message.
2
EFTA_R1_02037905
EFTA02693496
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Phone
2693495Phone
2693496Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
OtherUnknown
FEDWIRE PAYMENT DEBIT ADVICE
DOJ EFTA Data Set 10 document EFTA01273102
16p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.